Trial Of Hypofractionated Radiotherapy In Combination With MEDI4736 And Tremelimumab For Patients With Metastatic Melanoma And Lung, Breast And Pancreatic Cancers
Clinical trial NCT02639026 · COMPLETED
Trial details
- NCT number
- NCT02639026
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-26
- Primary completion
- 2023-06-27
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.